Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAX
2024-511008-17-00Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Lacosamide arm with Duloxetine arm (2 arms). Primary endpoint: Pain intensity score during the last 4 weeks of treatment. Started Jul 2024; status: completed.
02
Drugs
lacosamideduloxetine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on 2024-511008-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511008-17-00.